Metabolomic analysis of liver tissue from the vx2 rabbit model of secondary liver tumors

HPB Surgery

Volumn 2014, Issue , 2014, Pages

  Ibarra, R ^a   Dazard, J E ^b   Sandlers, Y ^a   Rehman, F ^a   Abbas, R ^a   Kombu, R ^a   Zhang, G F ^a   Brunengraber, H ^a   Sanabria, J ^a,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CANCER TREATMENT CENTERS OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896487589     PISSN: 08948569     EISSN: 16078462     Source Type: Journal    
DOI: 10.1155/2014/310372     Document Type: Article

References (60)

1. World Health Organization, Cancer. Fact Sheet 2009 297. http://www.who.int/mediacentre/factsheets/fs297/en/
2. Sherman M., Peltekian K. M., Lee C., Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995 22 2 432 438 2-s2.0-0029153698
3. Abbas R., Kombu R. S., Ibarra R. A., Goyal K. K., Brunengraber H., Sanabria J. R., The dynamics of glutathione species and ophthalmate concentrations in plasma from the VX2 rabbit model of secondary liver tumors. HPB Surgery 2011 2011 8 2-s2.0-79953275365 10.1155/2011/709052 709052
4. Vinayavekhin N., Homan E. A., Saghatelian A., Exploring disease through metabolomics. ACS Chemical Biology 2010 5 1 91 103 2-s2.0-75749136966 10.1021/cb900271r
5. Ryan D., Robards K., Metabolomics: the greatest omics of them all? Analytical Chemistry 2006 78 23 7954 7958 2-s2.0-33845325218 10.1021/ac0614341 (Pubitemid 44871759)
6. Griffin J. L., Kauppinen R. A., Tumour metabolomics in animal models of human cancer. Journal of Proteome Research 2007 6 2 498 505 2-s2.0-33847370301 10.1021/pr060464h (Pubitemid 46340153)
7. Griffin J. L., Shockcor J. P., Metabolic profiles of cancer cells. Nature Reviews Cancer 2004 4 7 551 561 2-s2.0-3042823722 (Pubitemid 38868624)
8. Yang C., Richardson A. D., Smith J. W., Osterman A., Comparative metabolomics of breast cancer. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2007 181 192 2-s2.0-36048945250
9. Gao P., Lu C., Zhang F., Sang P., Yang D., Li X., Kong H., Yin P., Tian J., Lu X., Lu A., Xu G., Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis. Analyst 2008 133 9 1214 1220 2-s2.0-49849105974 10.1039/b807369d
10. Tiziani S., Lopes V., Günther U. L., Early stage diagnosis of oral cancer using 1H NMR-Based metabolomics1,2. Neoplasia 2009 11 3 269 276 2-s2.0-62549138339 10.1593/neo.81396
11. Odunsi K., Wollman R. M., Ambrosone C. B., Hutson A., McCann S. E., Tammela J., Geisler J. P., Miller G., Sellers T., Cliby W., Qian F., Keitz B., Intengan M., Lele S., Alderfer J. L., Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. International Journal of Cancer 2005 113 5 782 788 2-s2.0-19944426814 10.1002/ijc.20651 (Pubitemid 40101260)
12. Ippolito J. E., Xu J., Jain S., Moulder K., Mennerick S., Crowley J. R., Townsend R. R., Gordon J. I., An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proceedings of the National Academy of Sciences of the United States of America 2005 102 28 9901 9906 2-s2.0-22244441842 10.1073/pnas.0500756102 (Pubitemid 40993665)
13. Wu H., Xue R., Dong L., Liu T., Deng C., Zeng H., Shen X., Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Analytica Chimica Acta 2009 648 1 98 104 2-s2.0-67650388695 10.1016/j.aca.2009.06.033
14. Gao H., Lu Q., Liu X., Cong H., Zhao L., Wang H., Lin D., Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Cancer Science 2009 100 4 782 785 2-s2.0-67449085093 10.1111/j.1349-7006.2009.01086.x
15. Yang J., Xu G., Zheng Y., Kong H., Pang T., Lv S., Yang Q., Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. Journal of Chromatography B 2004 813 1-2 59 65 2-s2.0-8844261879 10.1016/j.jchromb.2004.09.032 (Pubitemid 39535429)
16. Chen J., Wang W., Lv S., Yin P., Zhao X., Lu X., Zhang F., Xu G., Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Analytica Chimica Acta 2009 650 1 3 9 2-s2.0-69249140995 10.1016/j.aca.2009.03. 039
17. Xue R., Lin Z., Deng C., Dong L., Liu T., Wang J., Shen X., A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. Rapid Communications in Mass Spectrometry 2008 22 19 3061 3068 2-s2.0-56149092963 10.1002/rcm.3708
18. Ortega Á. D., Sánchez-Aragó M., Giner-Sánchez D., Sánchez-Cenizo L., Willers I., Cuezva J. M., Glucose avidity of carcinomas. Cancer Letters 2009 276 2 125 135 2-s2.0-61349164207 10.1016/j.canlet.2008.08.007
19. Warburg O., On the origin of cancer cells. Science 1956 123 3191 309 314 2-s2.0-12444279265
20. Christofk H. R., Vander Heiden M. G., Harris M. H., Ramanathan A., Gerszten R. E., Wei R., Fleming M. D., Schreiber S. L., Cantley L. C., The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008 452 7184 230 233 2-s2.0-40749163248 10.1038/nature06734 (Pubitemid 351380249)
21. Southam A. D., Easton J. M., Stentiford G. D., Ludwig C., Arvanitis T. N., Viant M. R., Metabolic changes in flatfish hepatic tumours revealed by NMR-based metabolomics and metabolic correlation networks. Journal of Proteome Research 2008 7 12 5277 5285 2-s2.0-61349135679 10.1021/pr800353t
22. Yang Y., Li C., Nie X., Feng X., Chen W., Yue Y., Tang H., Deng F., Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. Journal of Proteome Research 2007 6 7 2605 2614 2-s2.0-34547171180 10.1021/pr070063h (Pubitemid 47122355)
23. Shope R. E., Hurst E. W., Infectious papillomatosis of rabbits: with a note on the histopathology. The Journal of Experimental Medicine 1933 58 607 624
24. Chen J. H., Lin Y. C., Huang Y. S., Chen T. J., Lin W. Y., Han K. W., Induction of VX2 carcinoma in rabbit liver: comparison of two inoculation methods. Laboratory Animals 2004 38 1 79 84 2-s2.0-1642422240 10.1258/00236770460734434 (Pubitemid 38117449)
25. Liang B., Zheng C.-S., Feng G.-S., Wu H.-P., Wang Y., Zhao H., Qian J., Liang H.-M., Correlation of hypoxia-inducible factor 1 α with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model. CardioVascular and Interventional Radiology 2010 33 4 806 812 2-s2.0-77956184282 10.1007/s00270-009-9762-9
26. Weinberg B. D., Blanco E., Lempka S. F., Anderson J. M., Exner A. A., Gao J., Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment. Journal of Biomedical Materials Research A 2007 81 1 205 213 2-s2.0-33947192941 10.1002/jbm.a.30926 (Pubitemid 46435468)
27. Vali M., Vossen J. A., Buijs M., Engles J. M., Liapi E., Ventura V. P., Khwaja A., Acha-Ngwodo O., Shanmugasundaram G., Syed L., Wahl R. L., Geschwind J.-F. H., Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study. Journal of Pharmacology and Experimental Therapeutics 2008 327 1 32 37 2-s2.0-52649158301 10.1124/jpet.108.141093
28. Deng J., Virmani S., Yang G.-Y., Tang R., Woloschak G., Omary R. A., Larson A. C., Intraprocedural diffusion-weighted PROPELLER MRI to guide percutaneous biopsy needle placement within rabbit VX2 liver tumors. Journal of Magnetic Resonance Imaging 2009 30 2 366 373 2-s2.0-68049146066 10.1002/jmri.21840
29. Rous P., Kidd J. G., Smith W. E., Experiments on the cause of the rabbit carcinomas derived from virus-induced papillomas. II. Loss by the Vx2 carcinoma of the power to immunize hosts against the papilloma virus. The Journal of Experimental Medicine 1952 96 159 174
30. Styczynski M. P., Moxley J. F., Tong L. V., Walther J. L., Jensen K. L., Stephanopoulos G. N., Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. Analytical Chemistry 2007 79 3 966 973 2-s2.0-33847002010 10.1021/ac0614846
31. Dazard J.-E., Sunil Rao J., Joint adaptive meanvariance regularization and variance stabilization of high dimensional data. Computational Statistics and Data Analysis 2012 56 7 2317 2333 2-s2.0-84857633258 10.1016/j.csda.2012.01. 012
32. Dazard J.-E., Xu H., Santana A., MVR R package: mean variance regularization. Comprehensive R Archive Network, 2011
33. Efron B., Robbins, empirical Bayes and microarrays. The Annals of Statistics 2003 31 2 366 378 2-s2.0-0038364283 10.1214/aos/1051027871
34. Efron B., Tibshirani R., Storey J. D., Tusher V., Empirical bayes analysis of a microarray experiment. Journal of the American Statistical Association 2001 96 456 1151 1160 2-s2.0-1542784653 (Pubitemid 33695570)
35. Lönnstedt I., Rimini R., Nilsson P., Empirical bayes microarray ANOVA and grouping cell lines by equal expression levels. Statistical Applications in Genetics and Molecular Biology 2005 4, article 7 2-s2.0-19144372678
36. Newton M. A., Kendziorski C. M., Richmond C. S., Blattner F. R., Tsui K. W., On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. Journal of Computational Biology 2001 8 1 37 52 2-s2.0-0034923013 10.1089/ 106652701300099074 (Pubitemid 32679478)
37. Smyth G. K., Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 2004 3 1, article 3 2-s2.0-4544341015
38. Kendziorski C. M., Newton M. A., Lan H., Gould M. N., On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles. Statistics in Medicine 2003 22 24 3899 3914 2-s2.0-0346888587 10.1002/sim.1548 (Pubitemid 38008708)
39. Newton M. A., Noueiry A., Sarkar D., Ahlquist P., Detecting differential gene expression with a semiparametric hierarchical mixture method. Biostatistics 2004 5 2 155 176 2-s2.0-4444235995 10.1093/biostatistics/5.2.155 (Pubitemid 41180221)
40. Storey J. D., The positive false discovery rate: a Bayesian interpretation and the q-value. The Annals of Statistics 2003 31 6 2013 2035 2-s2.0-0345822598 10.1214/aos/1074290335 (Pubitemid 38293903)
41. Benjamini Y., Hochberg Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 1995 57 289 300
42. Storey J. D., A direct approach to false discovery rates. Journal of the Royal Statistical Society B 2002 64 3 479 498 2-s2.0-0036020892 10.1111/1467-9868.00346
43. Liu P., Hwang J. T. G., Quick calculation for sample size while controlling false discovery rate with application to microarray analysis. Bioinformatics 2007 23 6 739 746 2-s2.0-34147178433 10.1093/bioinformatics/ btl664 (Pubitemid 46554726)
44. MacIntyre D. A., Jiménez B., Lewintre E. J., Martín C. R., Schäfer H., Ballesteros C. G., Mayans J. R., Spraul M., García-Conde J., Pineda-Lucena A., Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia 2010 24 4 788 797 2-s2.0-77950944945 10.1038/leu.2009.295
45. Griffiths J. R., McSheehy P. M. J., Robinson S. P., Troy H., Chung Y.-L., Leek R. D., Williams K. J., Stratford I. J., Harris A. L., Stubbs M., Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1 β (HIF-1 β): evidence of an anabolic role for the HIF-1 pathway. Cancer Research 2002 62 3 688 695 2-s2.0-0036468251 (Pubitemid 34126942)
46. Li Z.-F., Wang J., Huang C., Zhang S., Yang J., Jiang A., Zhou R., Pan D., Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis. Rapid Communications in Mass Spectrometry 2010 24 18 2765 2775 2-s2.0-79952108823
47. Pavlides S., Whitaker-Menezes D., Castello-Cros R., Flomenberg N., Witkiewicz A. K., Frank P. G., Casimiro M. C., Wang C., Fortina P., Addya S., Pestell R. G., Martinez-Outschoorn U. E., Sotgia F., Lisanti M. P., The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009 8 23 3984 4001 2-s2.0-74849087878
48. Bonuccelli G., Tsirigos A., Whitaker-Menezes D., Pavlides S., Pestell R. G., Chiavarina B., Frank P. G., Flomenberg N., Howell A., Martinez-Outschoorn U. E., Sotgia F., Lisanti M. P., Ketones and lactate "fuel" tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010 9 17 3506 3514 2-s2.0-77956419439 10.4161/cc.9.17.12731
49. Gall W. E., Beebe K., Lawton K. A., Adam K. P., Mitchell M. W., Nakhle P. J., Ryals J. A., Milburn M. V., Nannipieri M., Camastra S., Natali A., Ferrannini E., α -hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE 2010 5 5 2-s2.0-77956293821 10.1371/journal.pone.0010883 e10883
50. Biedroń R., Ciszek M., Tokarczyk M., Bobek M., Kurnyta M., Słominska E. M., Smoleński R. T., Marcinkiewicz J., 1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages. Archivum Immunologiae et Therapiae Experimentalis 2008 56 2 127 134 2-s2.0-42349098046 10.1007/s00005-008-0009-2
51. Momchilova A., Markovska T., Pankov R., Ha-ras-transformation alters the metabolism of phosphatidylethanolamine and phosphatidylcholine in NIH 3T3 fibroblasts. Cell Biology International 1999 23 9 603 610 2-s2.0-0033500474 10.1006/cbir.1999.0430 (Pubitemid 30125209)
52. Pumpo R., Sarnelli G., Spinella A., Budillon G., Cuomo R., The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production. American Journal of Gastroenterology 2001 96 4 1183 1187 2-s2.0-0035049509 10.1016/S0002-9270(01)02261-4 (Pubitemid 32319158)
53. Clark B. R., Murai J. T., Pomeranz A., Altered distribution and excretion of N1 methylnicotinamide in rats with Walker 256 carcinosarcoma. Cancer Research 1975 35 7 1727 1733 2-s2.0-0016823745
54. Kuykendall J. R., Cox R., Kinder D., 1-Methylnicotinamide stimulates cell growth and inhibits hemoglobin synthesis in differentiating murine erythroleukemia cells. Toxicology in Vitro 2007 21 8 1656 1662 2-s2.0-36048942385 10.1016/j.tiv.2007.05.017 (Pubitemid 350086879)
55. Chlopicki S., Swies J., Mogielnicki A., Buczko W., Bartus M., Lomnicka M., Adamus J., Gebicki J., 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/ prostacyclin pathway. British Journal of Pharmacology 2007 152 2 230 239 2-s2.0-34948823247 10.1038/sj.bjp.0707383 (Pubitemid 47517607)
56. Minuk G. Y., Gaba and hepatocellular carcinoma. Molecular and Cellular Biochemistry 2000 207 1-2 105 108 2-s2.0-0034093876 (Pubitemid 30399376)
57. Zhang X. K., Gauthier T., Burczynski F. J., Wang G. Q., Gong Y., Minuk G. Y., Changes in liver membrane potentials after partial hepatectomy in rats. Hepatology 1996 23 3 549 551 2-s2.0-0030009214 (Pubitemid 26087170)
58. Minuk G. Y., Zhang M., Gong Y., Minuk L., Dienes H., Pettigrew N., Kew M., Lipschitz J., Sun D., Decreased hepatocyte membrane potential differences and GABAA- β 3 expression in human hepatocellular carcinoma. Hepatology 2007 45 3 735 745 2-s2.0-33947432087 10.1002/hep.21562 (Pubitemid 46450625)
59. Sun D., Gong Y., Kojima H., Wang G., Ravinsky E., Zhang M., Minuk G. Y., Increasing cell membrane potential and GABAergic activity inhibits malignant hepatocyte growth. American Journal of Physiology-Gastrointestinal and Liver Physiology 2003 285 1 G12 G19 2-s2.0-0037663791 (Pubitemid 36736383)
60. Nakanishi M., Rosenberg D. W., Roles of cPLA2 α and arachidonic acid in cancer. Biochimica et Biophysica Acta 2006 1761 11 1335 1343 2-s2.0-33750964503 10.1016/j.bbalip.2006.09.005 (Pubitemid 44738711) Kidney Diseases Kidney Diseases